The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer.
The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer.
复制标题
头颈癌中 PD-1/PD-L1 通路的演变
DOI:
10.3389/fimmu.2020.01721
复制
发表时间:
2020
影响因子:
7.3
通讯作者:
Tang YL
中科院分区:
文献类型:
--
作者:
Qiao XW;Jiang J;Pang X;Huang MC;Tang YJ;Liang XH;Tang YL
Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. Compared with traditional therapies, the emerging PD-1/PD-L1 blockade immunotherapy exhibited more satisfactory curative effects and lower toxicity for patients with advanced head and neck squamous cell carcinoma (HNSCC). This review analyzes the expression characteristics and clinical significance of PD-1/PD-L1 in HNSCC, the immunosuppressive roles of tumor cell and stromal cell expressing PD-1/PD-L1 in this disease, and presents the development landscape of PD-1/PD-L1 inhibitors, which may provide new curative alternatives for recurrent or metastatic HNSCC.
登录
查看更多内容
影响因子:
24.3
作者:
Cubillos-Zapata, Carolina;Angel Martinez-Garcia, Miguel;Garcia-Rio, Francisco
通讯作者:
Garcia-Rio, Francisco
影响因子:
11.5
作者:
Dorsey, Kelly;Agulnik, Mark
通讯作者:
Agulnik, Mark
影响因子:
30.5
作者:
Blackburn, Shawn D.;Shin, Haina;Haining, W. Nicholas;Zou, Tao;Workman, Creg J.;Polley, Antonio;Betts, Michael R.;Freeman, Gordon J.;Vignali, Dario A. A.;Wherry, E. John
通讯作者:
Wherry, E. John
影响因子:
4.8
作者:
Cramer JD;Burtness B;Ferris RL
通讯作者:
Ferris RL
影响因子:
64.8
作者:
Burr ML;Sparbier CE;Chan YC;Williamson JC;Woods K;Beavis PA;Lam EYN;Henderson MA;Bell CC;Stolzenburg S;Gilan O;Bloor S;Noori T;Morgens DW;Bassik MC;Neeson PJ;Behren A;Darcy PK;Dawson SJ;Voskoboinik I;Trapani JA;Cebon J;Lehner PJ;Dawson MA
通讯作者:
Dawson MA